These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2420605)

  • 21. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmembrane ion conductance in human B lymphocyte activation.
    Brent LH; Butler JL; Woods WT; Bubien JK
    J Immunol; 1990 Oct; 145(8):2381-9. PubMed ID: 1698853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interference of T cell activation by calcium channel blocking agents.
    Birx DL; Berger M; Fleisher TA
    J Immunol; 1984 Dec; 133(6):2904-9. PubMed ID: 6092460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
    J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibition of interleukin 2- and interleukin 4-mediated human B cell proliferation by ionomycin: a possible regulatory role for apoptosis.
    Vazquez A; Auffredou MT; Chaouchi N; Taieb J; Sharma S; Galanaud P; Leca G
    Eur J Immunol; 1991 Oct; 21(10):2311-6. PubMed ID: 1915547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.
    Cupps TR; Gerrard TL; Falkoff RJ; Whalen G; Fauci AS
    J Clin Invest; 1985 Feb; 75(2):754-61. PubMed ID: 3871795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
    Perri RT; Wilson BS; Kay NE
    Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular signaling events associated with the induction of DNA synthesis in human B lymphocytes. I. Stimulation of PKC-dependent and -independent pathways by LMW-BCGF.
    Kolb JP; Tran PL; Abadie A; Amirand C; Dugas B; Dugas B
    Cell Immunol; 1993 Jan; 146(1):117-30. PubMed ID: 8381050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of diacetyl diamines on in vitro activation and proliferation of human B lymphocytes.
    Lacy J; Summers WC; Canellakis ZN
    J Immunol; 1985 Dec; 135(6):3772-6. PubMed ID: 3877754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
    Ambrus JL; Peters MG; Fauci AS; Brown EJ
    J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
    Hu CP; Aman P; Masucci MG; Klein E; Klein G
    Eur J Immunol; 1986 Jul; 16(7):841-5. PubMed ID: 3013647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.